Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage

Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage

ObjectiveTo explore the efficacy and safety of nafamostat mesylate (NM) in patients on continuous renal replacement therapy (CRRT) at a high risk of hemorrhage.MethodsFrom March 2021 to February 2022, a retrospective study was conducted for 61 CRRT patients at a high risk of hemorrhage in intensive...

Full description

Bibliographic Details
Main Authors: Jia-rong Ding, Huan Zhang, Wei Chen, Jun-hua Zhao, Xin-rui Liang, Zhi-yong Guo
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2024-02-01
Series:Linchuang shenzangbing zazhi
Subjects:
high hemorrhagic risk
continuous renal replacement therapy
nafamostat mesylate
anticoagulation
Online Access:http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.02.002

Internet

http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.02.002

Similar Items